- Home
- CRL vs BEPC Comparison
CRL vs BEPC Comparison
Compare CRL & BEPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRL
- BEPC
- Stock Information
- Founded
- CRL 1947
- BEPC 2019
- Country
- CRL United States
- BEPC United States
- Employees
- CRL N/A
- BEPC N/A
- Industry
- CRL Biotechnology: Commercial Physical & Biological Resarch
- BEPC Electric Utilities: Central
- Sector
- CRL Health Care
- BEPC Utilities
- Exchange
- CRL Nasdaq
- BEPC Nasdaq
- Market Cap
- CRL 7.3B
- BEPC 7.3B
- IPO Year
- CRL 2000
- BEPC N/A
- Fundamental
- Price
- CRL $168.10
- BEPC $43.94
- Analyst Decision
- CRL Buy
- BEPC Buy
- Analyst Count
- CRL 16
- BEPC 4
- Target Price
- CRL $190.86
- BEPC $37.50
- AVG Volume (30 Days)
- CRL 1.1M
- BEPC 1.1M
- Earning Date
- CRL 11-05-2025
- BEPC 11-05-2025
- Dividend Yield
- CRL N/A
- BEPC 3.48%
- EPS Growth
- CRL N/A
- BEPC N/A
- EPS
- CRL N/A
- BEPC N/A
- Revenue
- CRL $4,023,704,000.00
- BEPC $3,828,000,000.00
- Revenue This Year
- CRL N/A
- BEPC $43.05
- Revenue Next Year
- CRL $2.43
- BEPC $9.08
- P/E Ratio
- CRL N/A
- BEPC N/A
- Revenue Growth
- CRL N/A
- BEPC N/A
- 52 Week Low
- CRL $91.86
- BEPC $23.73
- 52 Week High
- CRL $230.02
- BEPC $44.71
- Technical
- Relative Strength Index (RSI)
- CRL 41.64
- BEPC 68.24
- Support Level
- CRL $160.01
- BEPC $41.91
- Resistance Level
- CRL $180.19
- BEPC $44.53
- Average True Range (ATR)
- CRL 6.82
- BEPC 1.28
- MACD
- CRL -2.82
- BEPC 0.10
- Stochastic Oscillator
- CRL 20.40
- BEPC 87.16
About CRL Charles River Laboratories International Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
About BEPC Brookfield Renewable Corporation
Brookfield Renewable is a globally diversified, multitechnology owner and operator of clean energy assets. The company's portfolio consists of hydroelectric, wind, solar, and storage facilities in North America, South America, Europe, and Asia, and totals over 40 gigawatts of installed capacity. Brookfield Renewable invests in assets directly, as well as with institutional partners, joint venture partners, and through other arrangements. The company offers two separate listings for investors: Brookfield Renewable Partners LP and Brookfield Renewable Corp.